ANXIETY is the #6 most commonly reported adverse reaction for METHYLPHENIDATE HYDROCHLORIDE, manufactured by Sandoz Inc. There are 2,755 FDA adverse event reports linking METHYLPHENIDATE HYDROCHLORIDE to ANXIETY. This represents approximately 2.7% of all 101,957 adverse event reports for this drug.
Patients taking METHYLPHENIDATE HYDROCHLORIDE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ANXIETY2,755 of 101,957 reports
ANXIETY is a less commonly reported adverse event for METHYLPHENIDATE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of METHYLPHENIDATE HYDROCHLORIDE
In addition to anxiety, the following adverse reactions have been reported for METHYLPHENIDATE HYDROCHLORIDE:
ANXIETY has been reported as an adverse event in 2,755 FDA reports for METHYLPHENIDATE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ANXIETY with METHYLPHENIDATE HYDROCHLORIDE?
ANXIETY accounts for approximately 2.7% of all adverse event reports for METHYLPHENIDATE HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience ANXIETY while taking METHYLPHENIDATE HYDROCHLORIDE?
If you experience anxiety while taking METHYLPHENIDATE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.